RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+16%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$434M
AUM Growth
+$154M
(+55%)
Cap. Flow
+$135M
Cap. Flow
% of AUM
31.23%
Top 10 Holdings %
Top 10 Hldgs %
39.11%
Holding
88
New
19
Increased
48
Reduced
6
Closed
13
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$24.6M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$10.1M |
| 3 |
ITMN
INTERMUNE INC
ITMN
|
$9.54M |
| 4 |
AbbVie
ABBV
|
$6.94M |
| 5 |
UnitedHealth
UNH
|
$6.64M |
Top Sells
| 1 |
Health Care Select Sector SPDR Fund
XLV
|
$9.94M |
| 2 |
GENT
GENTIUM SPA ADS
GENT
|
$6.82M |
| 3 |
AET
Aetna Inc
AET
|
$4.27M |
| 4 |
Puma Biotechnology
PBYI
|
$2.89M |
| 5 |
Edwards Lifesciences
EW
|
$2.8M |
Sector Composition
| 1 | Healthcare | 79.37% |
| 2 | Industrials | 1.53% |
| 3 | Technology | 0.49% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cardinal Health
CAH
$35.7B
| $5.32M | 1.23% |
76,000
+12,000
| +19% | +$840K |
|
|
FRX
27
DELISTED
FOREST LABORATORIES INC
FRX
| $4.98M | 1.15% |
54,000
+20,000
| +59% | +$1.85M |
|
28
Neurocrine Biosciences
NBIX
$14.3B
| $4.83M | 1.11% |
+300,000
| New | +$4.83M |
|
|
HTWR
29
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $4.69M | 1.08% |
50,000
+17,250
| +53% | +$1.62M |
|
|
WBA
30
DELISTED
Walgreens Boots Alliance
WBA
| $4.66M | 1.07% |
70,500
+6,500
| +10% | +$429K |
|
|
EVHC
31
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $4.65M | 1.07% |
+45,925
| New | +$4.65M |
|
32
Perrigo
PRGO
$3.12B
| $4.41M | 1.02% |
+28,500
| New | +$4.41M |
|
|
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.29M | 0.99% |
13,000
-3,500
| -21% | -$1.15M |
|
34
Pacira BioSciences
PCRX
$1.19B
| $4.27M | 0.98% |
61,000
+10,500
| +21% | +$735K |
|
|
TSRO
35
DELISTED
TESARO, Inc.
TSRO
| $3.82M | 0.88% |
129,500
+71,250
| +122% | +$2.1M |
|
36
Universal Health Services
UHS
$12.1B
| $3.69M | 0.85% |
45,000
+16,500
| +58% | +$1.35M |
|
|
SRCL
37
DELISTED
Stericycle Inc
SRCL
| $3.52M | 0.81% |
+31,000
| New | +$3.52M |
|
38
HCA Healthcare
HCA
$98.5B
| $3.52M | 0.81% |
67,000
+9,000
| +16% | +$473K |
|
|
FPRX
39
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.44M | 0.79% |
+175,000
| New | +$3.44M |
|
|
MDCO
40
DELISTED
Medicines Co
MDCO
| $3.41M | 0.79% |
120,000
+87,500
| +269% | +$2.49M |
|
41
Incyte
INCY
$16.9B
| $3.4M | 0.78% |
63,500
+22,000
| +53% | +$1.18M |
|
|
CVD
42
DELISTED
COVANCE INC.
CVD
| $3.38M | 0.78% |
32,500
+7,000
| +27% | +$727K |
|
|
WCG
43
DELISTED
Wellcare Health Plans, Inc.
WCG
| $3.27M | 0.75% |
51,500
+35,000
| +212% | +$2.22M |
|
|
PCYC
44
DELISTED
PHARMACYCLICS INC
PCYC
| $3.16M | 0.73% |
31,500
+13,000
| +70% | +$1.3M |
|
|
ATHN
45
DELISTED
Athenahealth, Inc.
ATHN
| $3.13M | 0.72% |
19,500
| – | – |
|
46
Charles River Laboratories
CRL
$8.07B
| $2.99M | 0.69% |
+49,500
| New | +$2.99M |
|
|
DRNA
47
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.97M | 0.68% |
+105,000
| New | +$2.97M |
|
|
CO
48
DELISTED
Global Cord Blood Corporation
CO
| $2.87M | 0.66% |
717,500
+342,889
| +92% | +$1.37M |
|
|
FEIC
49
DELISTED
FEI COMPANY
FEIC
| $2.83M | 0.65% |
27,500
+3,000
| +12% | +$309K |
|
|
SRGA
50
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.8M | 0.65% |
+22,879
| New | +$2.8M |
|